(Q53976284)

23 May 2018

review article

1 reference

title

[Biological basis of combined chemo-radiotherapy. Applications to lung cancers] (English)

1 reference

23 May 2018

adaptive radiation therapy

main subject

0 references

author name string

Mornex F

series ordinal

1

1 reference

23 May 2018

Van Houtte P

series ordinal

2

1 reference

23 May 2018

Cosset JM

series ordinal

3

1 reference

23 May 2018

publication date

1 January 1997

1 reference

23 May 2018

published in

Cancer Radiothérapie

1 reference

23 May 2018

volume

1

1 reference

23 May 2018

issue

1

1 reference

23 May 2018

page(s)

29-41

1 reference

23 May 2018

Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Cisplatin and radiation: interaction probabilities and therapeutic possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

1 reference

7 January 2021

[Conforming radiotherapy in 1995: technological acquisitions and clinical prospects]

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

[Apoptosis and radiotherapy]

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Drug-induced DNA damage and tumor chemosensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: Results of a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Chemotherapy of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Apoptosis. Its significance in cancer and cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Rationale for different chemotherapeutic and radiation therapy strategies in cancer management

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Concurrent chemotherapy (CT) and radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC): a review

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Combined modality treatment with radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

The combination of radiotherapy and chemotherapy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Induction or concomitant chemotherapy and radiotherapy for non-small-cell lung cancer: myth or reality

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Optimization of radical radiotherapy with beam's eye view techniques for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2984054-1

7 January 2021

10.1016/S1278-3218(97)84054-1

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018